http://www.unboundmedicine.com/medline/ebm/research/dexrazoxaneUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19915982/full_citation/Mechanisms_of_Myocyte_Cytotoxicity_Induced_by_the_Multikinase_Inhibitor_Sorafenib_Hasinoff BB, Patel D 
Mechanisms of Myocyte Cytotoxicity Induced by the Multikinase Inhibitor Sorafenib. [JOURNAL ARTICLE]
Cardiovasc Toxicol 2009 Nov 14.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19915844/full_citation/Early_alterations_in_heart_gene_expression_profiles_associated_with_doxorubicin_cardiotoxicity_in_rats_Thompson KL, Rosenzweig BA, Zhang J, et al. 
Early alterations in heart gene expression profiles associated with doxorubicin cardiotoxicity in rats. [JOURNAL ARTICLE]
Cancer Chemother Pharmacol 2009 Nov 14.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19845502/full_citation/Anticancer_Activities_and_Mechanisms_of_Bisdioxopiperazine_Compounds_Probimane_and_MST_16_Lu DY, Lu TR 
Anticancer Activities and Mechanisms of Bisdioxopiperazine Compounds Probimane and MST-16. [JOURNAL ARTICLE]
Anticancer Agents Med Chem 2009 Oct 22.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19841470/full_citation/Sub_lethal_doses_of_an_anti_erbB2_antibody_leads_to_death_by_apoptosis_in_cardiomyocytes_sensitized_by_low_pro_senescent_doses_of_epirubicin:_the_protective_role_of_dexrazoxane_Spallarossa P, Altieri P, Pronzato P, et al. 
Sub-lethal doses of an anti-erbB2 antibody leads to death by apoptosis in cardiomyocytes sensitized by low pro-senescent doses of epirubicin: the protective role of dexrazoxane. [JOURNAL ARTICLE]
J Pharmacol Exp Ther 2009 Oct 19.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19738618/full_citation/Induction_of_thrombospondin_1_partially_mediates_the_anti_angiogenic_activity_of_dexrazoxane_Maloney SL, Sullivan DC, Suchting S, et al. 
Induction of thrombospondin-1 partially mediates the anti-angiogenic activity of dexrazoxane. [Journal Article, Research Support, Non-U.S. Gov't]
Br J Cancer 2009 Sep 15; 101(6):957-66.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19703166/full_citation/Dexrazoxane_protects_the_heart_from_acute_doxorubicin_induced_QT_prolongation:_a_key_role_for_I_Ducroq J, Moha Ou Maati H, Guilbot S, et al. 
Dexrazoxane protects the heart from acute doxorubicin-induced QT prolongation: a key role for I. [JOURNAL ARTICLE]
Br J Pharmacol 2009 Aug 24.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19688963/full_citation/Anthracycline_extravasation:_a_comprehensive_review_of_experimental_and_clinical_treatments_Langer SW, Sehested M, Jensen PB 
Anthracycline extravasation: a comprehensive review of experimental and clinical treatments. [Journal Article]
Tumori 2009 May-Jun; 95(3):273-82.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19623174/full_citation/Dexrazoxane_afforded_protection_against_chronic_anthracycline_cardiotoxicity_in_vivo:_effective_rescue_of_cardiomyocytes_from_apoptotic_cell_death_Popelová O, Stěrba M, Hašková P, et al. 
Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death. [JOURNAL ARTICLE]
Br J Cancer 2009 Jul 21.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19536310/full_citation/Anthracycline_extravasation_injuries:_management_with_dexrazoxane_Jordan K, Behlendorf T, Mueller F, et al. 
Anthracycline extravasation injuries: management with dexrazoxane. [Journal Article]
Ther Clin Risk Manag 2009 Apr; 5(2):361-6.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19535146/full_citation/The_iron_chelator_Dp44mT_does_not_protect_myocytes_against_doxorubicin_Hasinoff BB, Patel D 
The iron chelator Dp44mT does not protect myocytes against doxorubicin. [JOURNAL ARTICLE]
J Inorg Biochem 2009 May 21.
Abstract | Full Citation